STAT

SEPTEMBER 8, 2023

They came bearing gold letter balloons spelling out LFVN, the stock symbol for LifeVantage, the company they’d come to promote, and foam cutouts of its navy blue supplement bottles. ” At first glance, LifeVantage, worth some $84 million, looks decidedly mainstream.

Vaccines 363

Vaccines 363

STAT

APRIL 3, 2024

Instead, the company’s technology maps the proximity of cancer cells, healthy cells, and proteins.

346

346

STAT

MAY 1, 2024

On Wednesday, Metagenomi announced the two companies broke off  the collaboration after three years of research. “This will be a completely new approach for Moderna and a dramatic expansion of our modality strategy,” Moderna president Stephen Hogue told investors. Those efforts appear to have hit some road bumps.

Vaccines 305

Vaccines 305

STAT

APRIL 10, 2024

A small company called Harrow argues that it can make the case for an injectable eye treatment that has been used to combat several serious conditions. In an era when huge price hikes for prescription drugs are almost guaranteed to draw criticism, is there any circumstance when a 486% increase for a medicine might appear to be justified?

Drug Pricing 356

Drug Pricing 356

STAT

MARCH 4, 2024

Over the last few years, virtual mental health company Talkspace has been on a relentless quest to conquer the insurance market. The next step in that journey, Medicare, may prove the most challenging yet. Talkspace’s pivot away from its direct-to-consumer roots has so far been a success.

336

336

STAT

NOVEMBER 28, 2023

Investors , analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable conclusions is a challenging task.

Drug Development 342

Drug Development 342

PharmaVoice

FEBRUARY 2, 2024

Explosive demand for weight loss drugs has propelled both companies to new heights. Here’s a look at the staggering growth, by the numbers.

263

263

STAT

JANUARY 18, 2024

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. Even after hitting roadblock after roadblock, the company stuck to its original plan and ended up vaporizing over $400 million in investment before finally throwing in the towel.

335

335

STAT

DECEMBER 7, 2023

The news comes three months after Insulet, EOFlow’s rival, filed a lawsuit accusing the company of stealing trade secrets. The device giant first announced the acquisition in May for $738 million, giving the company its first tubeless pump. Medtronic is no longer buying EOFlow, a Korean maker of wearable insulin pumps.

Diabetes 331

Diabetes 331

STAT

MARCH 21, 2024

The efforts, which are being joined by some some lawmakers, reflect concerns that patients may lose access to these medicines if pharmaceutical companies halt sales or decide not to invest in developing such drugs. Continue to STAT+ to read the full story…

Pharmaceutical Companies 332

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 332

STAT

DECEMBER 19, 2023

Amy Abernethy, the president of product development and chief medical officer at Verily, a health care spinout of search giant Alphabet, will leave the company at the end of the first quarter to start a nonprofit aimed at changing the way the health care system collects data.

352

352

STAT

OCTOBER 17, 2023

Revenue cycle management company Waystar filed for an initial public offering Monday with the Securities and Exchange Commission. The company did not specify how many shares it plans to offer or what share price it is targeting. billion market cap.

Hospitals 265

Hospitals 265

STAT

DECEMBER 21, 2023

WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. As a result, several major medical marijuana companies have amassed billion- or multibillion-dollar valuations. But they’re not playing by the same rules — and that’s putting patients at risk.

Pharmaceutical Companies 338

Pharmaceutical Companies Pharmaceutical Companies 338

STAT

SEPTEMBER 28, 2023

This article is adapted from STAT’s exclusive analysis in the STAT Report: “Climate rankings: How top drug companies measure up in combating climate change.” ” D rug companies are major contributors to climate change, both through direct greenhouse gas emissions and especially through their supply chains.

353

353

STAT

OCTOBER 2, 2023

Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week.

360

360

STAT

DECEMBER 20, 2023

The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.  From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

332

332

STAT

DECEMBER 13, 2023

PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers. “My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said.

304

304

STAT

DECEMBER 11, 2023

Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline. The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech.

Labelling 354

Labelling 354

PharmaVoice

JUNE 22, 2023

These six Big Pharma companies have ranked among the best places to work for LGTBQ+ equality by the Human Rights Campaign Foundation for over 10 years. Here’s why.

246

246

STAT

APRIL 2, 2024

The autoimmune drug, brepocitinib, is being steered by a company called Priovant Therapeutics, which was formed as part of a deal between Roivant and Pfizer in 2021.   Roivant, which has been flush with cash since selling a drug candidate to Roche last year for $7.1 billion, also announced Tuesday it was launching a $1.5-billion

Compounding 299

Compounding Drug Development 299

STAT

FEBRUARY 26, 2024

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares. per share, or roughly $5.8

Hospitals 264

Hospitals 264

STAT

APRIL 8, 2024

A fully independent clinical trial researchers thought might disprove a cardiac device made by Shockwave Medical, the company that Johnson & Johnson is buying for $13 billion, ended up providing some support for the device’s utility. but was previously rejected by the U.S.

294

294

STAT

APRIL 12, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with what is my final edition of The Readout on my last day at STAT.

Drug Pricing 269

Drug Pricing Drug Development Vaccines 269

STAT

NOVEMBER 2, 2023

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

294

294

STAT

FEBRUARY 8, 2023

A new series of papers published in The Lancet — of which I am a co-author — makes clear that a key reason for this is the marketing tactics of companies selling formula.

246

246

Pharmaceutical Technology

MAY 2, 2024

From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies 111

STAT

DECEMBER 14, 2022

Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector.

Hospitals 363

Hospitals 363

STAT

NOVEMBER 13, 2023

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Diabetes 353

Diabetes Drug Development 353

PharmaVoice

APRIL 17, 2024

As the cliffs approach, pharma companies are tackling the sales hit with diverging strategies.

147

147

STAT

DECEMBER 14, 2023

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry. Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system.

Diabetes 350

Diabetes 350

pharmaphorum

FEBRUARY 29, 2024

Learn more about Marcus West and his company, 60 Seconds, specialising in coaching services to help individuals and teams reach their full potential.

111

111

STAT

JULY 26, 2023

It’s no secret that such hospitals, especially when run by for-profit companies, base admission decisions on how much they’ll get paid, but it’s rare to hear the practice described so bluntly.

Hospitals 246

Hospitals 246

STAT

APRIL 4, 2023

For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain.

Diabetes 346

Diabetes Drug Pricing 346

STAT

SEPTEMBER 5, 2023

Health care leaders and technology companies are investing heavily in large language models, a powerful class of deep learning models that are trained on vast troves of data. But while enthusiasm for generative AI is high and research is booming, it’s just starting to gain a toehold in clinical settings.

Hospitals 359

Hospitals 359

BioPharma Dive

APRIL 18, 2024

Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

101

101

Express Pharma

MAY 6, 2024

A significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. According to GlobalData, a significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. Half of the top 10 developers seek to capitalise on potential returns.

Chemotherapy 60

Chemotherapy 60

PharmaVoice

MAY 22, 2023

How these consumer and service companies are tapping into major trends in the biopharma industry.

264

264